Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosigotifator in Vanishing White Matter Disease
NCT05757141Phase 2Recruiting
- Sponsor
- Calico Life Sciences
- Start
- Mar 2023
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of fosigotifator in leukoencephalopathy with vanishing white matter (VWM), sponsored by Calico Life Sciences. Started Mar 2023; status: recruiting.
02
Drugs
fosigotifator
03
Conditions
leukoencephalopathy with vanishing white matter (VWM)
Beyond the preview
Go deeper on NCT05757141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05757141.